GB0313632D0 - Chemokine receptors - Google Patents

Chemokine receptors

Info

Publication number: GB0313632D0
Authority: GB; United Kingdom
Prior art keywords: chemokine receptors; chemokine; receptors
Prior art date: 2003-06-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0313632.2A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Neurotargets Ltd

Original Assignee

Neurotargets Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-12

Filing date

2003-06-12

Publication date

2003-07-16

2003-06-12 Application filed by Neurotargets Ltd filed Critical Neurotargets Ltd

2003-06-12 Priority to GBGB0313632.2A priority Critical patent/GB0313632D0/en

2003-07-16 Publication of GB0313632D0 publication Critical patent/GB0313632D0/en

2004-06-04 Priority to PCT/GB2004/002391 priority patent/WO2004110416A2/en

Status Ceased legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Hematology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Urology & Nephrology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB0313632.2A 2003-06-12 2003-06-12 Chemokine receptors Ceased GB0313632D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB0313632.2A GB0313632D0 (en)	2003-06-12	2003-06-12	Chemokine receptors
PCT/GB2004/002391 WO2004110416A2 (en)	2003-06-12	2004-06-04	Use of a cx3c agonist for the treatment of pain and for promoting nerve regeneration

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0313632.2A GB0313632D0 (en)	2003-06-12	2003-06-12	Chemokine receptors

Publications (1)

Publication Number	Publication Date
GB0313632D0 true GB0313632D0 (en)	2003-07-16

Family

ID=27589990

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0313632.2A Ceased GB0313632D0 (en)	2003-06-12	2003-06-12	Chemokine receptors

Country Status (2)

Country	Link
GB (1)	GB0313632D0 (en)
WO (1)	WO2004110416A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITRM20060353A1 (en) *	2006-07-06	2008-01-07	Istituto Neurologico Mediterra	USE OF FRACTALCHINA FOR THE PRODUCTION OF A NEUROPROTECTOR DRUG AGAINST CELL DEATH

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0101082D0 (en) *	2001-03-27	2001-03-27	Astrazeneca Ab	Novel use

2003
- 2003-06-12 GB GBGB0313632.2A patent/GB0313632D0/en not_active Ceased
2004
- 2004-06-04 WO PCT/GB2004/002391 patent/WO2004110416A2/en active Application Filing

Also Published As

Publication number	Publication date
WO2004110416A2 (en)	2004-12-23
WO2004110416A3 (en)	2005-05-26

Publication	Publication Date	Title
IL165841A0 (en)	2006-01-15	Mchir antagonists
GB2409502B (en)	2007-01-03	Connection
IL165727A0 (en)	2006-01-15	Chemokine antagonists
GB0315259D0 (en)	2003-08-06	Use
GB2406627B (en)	2008-05-07	Connecting arrangement
IL173337A0 (en)	2006-06-11	Receptor
GB0226227D0 (en)	2002-12-18	Receptors
GB0302741D0 (en)	2003-03-12	Use
GB0313632D0 (en)	2003-07-16	Chemokine receptors
GB0223399D0 (en)	2002-11-13	Receptors
GB0312139D0 (en)	2003-07-02	Bowls
PL1533429T3 (en)	2011-05-31	Connection
GB0321998D0 (en)	2003-10-22	Receptor
GB0314113D0 (en)	2003-07-23	Receptors
GB0316354D0 (en)	2003-08-13	Receptors
GB0308309D0 (en)	2003-05-14	Receptors
GB0304090D0 (en)	2003-03-26	Receptors
GB0304065D0 (en)	2003-03-26	Receptors
GB0304064D0 (en)	2003-03-26	Receptors
GB0302604D0 (en)	2003-03-12	Receptors
GB0321391D0 (en)	2003-10-15	Flexi-facial plus
GB0316757D0 (en)	2003-08-20	Use
GB0228112D0 (en)	2003-01-08	Receptors
GB0329104D0 (en)	2004-01-21	Receptor
GB0307100D0 (en)	2003-04-30	Receptor

Legal Events

Date	Code	Title	Description
2004-12-22	AT	Applications terminated before publication under section 16(1)